Additional indication for pediatric patients with severe eosinophilic asthma WILMINGTON, Del., April 11, 2024--(BUSINESS WIRE)--AstraZeneca’s FASENRA® (benralizumab) is now approved by the US Food and...
Source LinkAdditional indication for pediatric patients with severe eosinophilic asthma WILMINGTON, Del., April 11, 2024--(BUSINESS WIRE)--AstraZeneca’s FASENRA® (benralizumab) is now approved by the US Food and...
Source Link
Comments